The association of MHCII+ and Lyve1+ PVM populations with REVs might mediate immunomodulatory responses, and the predominant gene expression changes in REVs upon immunological challenge highlight further that these vessels might be critical for the immune privileged status of the CNS with potential implications for ageing and neurodegenerative diseases. The gene discussed is LYVE1; the disease is neurodegenerative disease.